Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Baxter
Johnson and Johnson
Harvard Business School
Express Scripts

Last Updated: December 3, 2022

Details for Patent: 7,419,973


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 7,419,973
Title:Phosphonocephem compound
Abstract:A cephem compound (particularly its crystal) represented by the formula [I], wherein X is CH.sub.3COOH, CH.sub.3CH.sub.2COOH or CH.sub.3CN, and n is 0 to 5, is useful as an antibacterial agent (particularly anti-MRSA agent) and shows superior quality such as high solid stability, possible long-term stable preservation and the like. ##STR00001##
Inventor(s): Ishikawa; Tomoyasu (Shiga, JP), Hashiguchi; Shohei (Osaka, JP), Iizawa; Yuji (Kyoto, JP)
Assignee: Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:11/063,715
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,419,973
Patent Claim Types:
see list of patent claims
Composition; Compound; Formulation;

Drugs Protected by US Patent 7,419,973

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,419,973

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2000-247966Aug 10, 2000
Japan2000-354959Nov 21, 2000

International Family Members for US Patent 7,419,973

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 431827 See Plans and Pricing
Australia 7775301 See Plans and Pricing
Canada 2418614 See Plans and Pricing
China 1189471 See Plans and Pricing
China 1462275 See Plans and Pricing
Cyprus 1109313 See Plans and Pricing
Germany 60138760 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Express Scripts
Mallinckrodt
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.